NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines

GGC Formulary
- 1 Gastro-intestinal system
- 2 Cardiovascular system
- 3 Respiratory system
- 4 Central nervous system
- 5 Infections
- 6 Endocrine system
- 7 Obstetrics, gynaecology and urinary-tract disorders
- 8 Malignant disease and immunosuppression
- 9 Nutrition and blood
- 10 Musculoskeletal and joint diseases
- 11 Eye
- 12 Ear, nose and oropharynx
- 13 Skin
- 14 Immunological products and vaccines
  - 14.4 Vaccines and antisera
  - 14.5 Immunoglobulins
- 15 Anaesthesia
  - 15.1 General anaesthesia
  - 15.2 Local anaesthesia
- 16 Treatment of poisoning
  - 16.1 Removal and elimination
  - 16.2 Specific antidotes
Latest Formulary Decisions
Medicines Update Blogs
Clinical Guidelines
Adult Therapeutics Handbook
COVID-19 (Coronavirus)
Medicines Policies
Other Formularies
PACS, IPTR and ULM
Patient Information
Prescribing Resources
Shared Care Agreements
Supply Problems (StaffNet)
Contact Us

Go Home

Subscribe to pregnancy via

Email Subscription

Latest Posts

Archives

Tags

pregnancy

Valproate and risk of abnormal pregnancy outcomes: new communication materials

Posted: March 14, 2016.
Category - Medicines Update
Tagged with - pregnancy valproate

Valproate and risk of abnormal pregnancy outcomes: new communication materials In January 2015, the Medicines and Healthcare products Regulatory Agency (MHRA) published

Showing 1 - 1 of 1 records. Page: 1

← Previous page | Next page →